Challenger

Challenger reported a normalized EPS of 0.6810 AUD and a normalized NPAT of 468 million AUD for FY 2026 (both +3%), while statutory NPAT rose to 506 million AUD (+163%). The company increased the dividend, expanded the share buyback program to 450 million AUD, and reported a strengthened capital position under the new APRA standards. For FY 2027 Challenger forecasts core EPS of 0.45–0.49 AUD, and the stock climbed 6.19% to 10.29 AUD following the results. » Altro su de.investing.com

Challenger reported normalized EPS of $0.333 for H1/26 (+2%) and normalized NPAT of $229m (+2%), while statutory NPAT rose to $339m (+369%) due to large investment gains. The company announced a $150m share buyback, increased the interim dividend by 7% to $0.155, and reaffirmed its full‑year guidance for normalized EPS of $0.66–0.72. Challenger highlights a strong capital position with a PCA ratio of 1.58x, sees growth potential in Australia and Asia, and is preparing for significant APRA capital standards. » Altro su de.investing.com